Back to Search Results
Craig Hofmeister
Schedule an appointment (614) 293-3196
Insurances We Accept
I specialize in treating people with multiple myeloma, AL amyloidosis and other blood cancers. I’m passionate about providing world-class care for the patients I see every day, and for the opportunity to find a cure at the OSUCCC – James. Our approach is very patient-centered, and we learn something new from everyone we see. The treatment we provide integrates compassionate care with the latest therapies and novel clinical trials. In 2014 and 2016, I was rated in the top 10 percent of physicians in the nation for patient satisfaction.

Much of our research explores ways to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, such as multiple myeloma. The idea is to “super-charge” the patient’s immune system so that it responds to the cancer by attacking it – all while offering the patient a drug-free treatment alternative.

In 2012 I became a member of the cancer institutional review board (IRB), in charge of ensuring patient safety for research at the OSUCCC – James. In 2013 I became a member of the steering committee of the Multiple Myeloma Research Consortium (MMRC), the clinical trial offshoot of the Multiple Myeloma Research Foundation (MMRF). This gives Ohio State representation and access to early phase multiple myeloma clinical trials with national representation. Additionally I serve as an associate professor of internal medicine for The Ohio State University.

The James is a wonderful environment to pursue cutting-edge treatment. The blood cancer group is comprised of about 50 leading physicians and scientists who’ve dedicated their careers to treatment and research. It’s a thrill to work with such dedicated colleagues in our common goal to end cancer once and for all.

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2016

Medical Degree

  • M.D.
    Ohio State University College of Medicine
    6/11/1999

Residency

  • Internal Medicine
    Loyola University Medical Center
    7/1/2000 - 6/30/2002

Additional languages I speak

  • Spanish

Specialties and conditions I treat

  • Hematology
  • Multiple Myeloma
  • Graft vs Host Disease
  • Bone Marrow Transplantation
  • Blood Cancers

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

More about my work

My background

Fellowships

  • Hematology/Oncology
    Loyola University Medical Center
    7/1/2002 - 6/30/2005
  • Transplant
    Loyola University Medical Center
    7/1/2005 - 6/30/2006

Board Certifications

American Board of Internal Medicine
8/20/2002

American Board of Internal Medicine (Subspecialty: Hematology)
11/18/2005

American Board of Internal Medicine (Subspecialty: Medicine Oncology)
11/16/2006

My Department

Internal Medicine

My Division

Hematology

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/28/17, Dr. Hofmeister has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.

  • Signal Genetics, Inc.